TOP PICK

Tough year 2023. Renewables sentiment turned, interest rates rose, turbine manufacturing problems. Pretty confident they can execute projects well. Long term, renewables aren't going off the map. At these levels, lots of optionality. The riskiest of his 3 Top Picks. He owns a lot and is buying more. Yield is 4.91%.

(Analysts’ price target is $31.09)
BUY

Was upgraded today and shares jumped 3.65%, citing good performance by Reels, more spending from Chinese advertising and What's App may be undervalued. Nothing new to him, because he's always been recommending Meta for these reasons.

BUY

An analyst recommend Palo Alto, Fortinet and Crowdstrike, citing tailwinds that continue to be increasing cyber-threats, SEC requiring companies to disclose hacks, and easier growth comps. Nothing new. He likes this space.

BUY

An analyst recommend Palo Alto, Fortinet and Crowdstrike, citing tailwinds that continue to be increasing cyber-threats, SEC requiring companies to disclose hacks, and easier growth comps. Nothing new. He likes this space.

BUY

An analyst recommend Palo Alto, Fortinet and Crowdstrike, citing tailwinds that continue to be increasing cyber-threats, SEC requiring companies to disclose hacks, and easier growth comps. Nothing new. He likes this space.

BUY

Jumped 3.06% today after an analyst upgrade, citing falling interest rates and that falling home sales are in the rearview mirror, so the inflection is in sight.

BUY

An analyst upgrade noted a re-accelerating topline and a good EPS growth compounder.

DON'T BUY
They bought a telehelp platform, so how will this help against the companies producing the popular weight-loss drugs?

Little effect, because you don't need WTW if everybody is taking these weight-loss drugs.

WEAK BUY

They have new management which knows how to monetize. We need more advertising names beside Meta and Alphabet.

DON'T BUY

An interest rate play. Stay away.

BUY

A great long-term performer, up 29% in the past year. Expanded their sales reach while solving their supply chain issues. Rebranded from AmerisourceBergen.

WEAK BUY

It reports Friday. Trades at an expensive 2x book value; it deserves this premium, but it's high. Trades at a low 10x PE. This can grind higher, but not soar.

DON'T BUY

BAC trades at a high 1.4x book value, but at low 10x PE. It's a show-me story that needs to release a few solid quarters in a row. But it offers an excellent digital banking platform and attractive dividend, but is unloved.

DON'T BUY

Citi trades at only 0.6x book value, cheapest among peers, but there may be something wrong with that. Trades at a low 10x PE. Last September, they announced a major restructuring, like cutting jobs and executive layers, and they already dropped many of their international businesses. Wall Street is excited by the many job cuts, but he thinks the growth is questionable. It's the only major bank expected to grow earnings in 2024 at 5.2%. He hopes they make a comeback, but will believe it when he sees it.

BUY

Wells trades at 1.3x book value, but at low 10x PE. Just suffered two downgrades, which he disagrees with. Management is highly focused on cutting costs, improving new technology, and they're getting away from their problematic past. He likes it that WFC is out of favour, because it's an opportunity.